ECG changes during haloperidol and pimozide treatment of Tourette's disorder - PubMed

Clinical Trial

ECG changes during haloperidol and pimozide treatment of Tourette's disorder

G Fulop et al. Am J Psychiatry. 1987 May.

Abstract

The ECG QTc interval was significantly prolonged by pimozide but not haloperidol or placebo in a randomized clinical trial with 40 patients with Tourette's disorder. However, no adverse cardiac effects or differences in rate, rhythm, or waveform were found.

Similar articles

• Controlled study of haloperidol, pimozide and placebo for the treatment of Gilles de la Tourette's syndrome.

  Shapiro E, Shapiro AK, Fulop G, Hubbard M, Mandeli J, Nordlie J, Phillips RA. Shapiro E, et al. Arch Gen Psychiatry. 1989 Aug;46(8):722-30. doi: 10.1001/archpsyc.1989.01810080052006. Arch Gen Psychiatry. 1989. PMID: 2665687 Clinical Trial.

• A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome.

  Ross MS, Moldofsky H. Ross MS, et al. Am J Psychiatry. 1978 May;135(5):585-7. doi: 10.1176/ajp.135.5.585. Am J Psychiatry. 1978. PMID: 347954 Clinical Trial.

• Relative efficacy of haloperidol and pimozide in children and adolescents with Tourette's disorder.

  Sallee FR, Nesbitt L, Jackson C, Sine L, Sethuraman G. Sallee FR, et al. Am J Psychiatry. 1997 Aug;154(8):1057-62. doi: 10.1176/ajp.154.8.1057. Am J Psychiatry. 1997. PMID: 9247389 Clinical Trial.

• Pimozide: use in Tourette's syndrome.

  Colvin CL, Tankanow RM. Colvin CL, et al. Drug Intell Clin Pharm. 1985 Jun;19(6):421-4. doi: 10.1177/106002808501900602. Drug Intell Clin Pharm. 1985. PMID: 3891283 Review.

• Pimozide for tics in Tourette's syndrome.

  Pringsheim T, Marras C. Pringsheim T, et al. Cochrane Database Syst Rev. 2009 Apr 15;2009(2):CD006996. doi: 10.1002/14651858.CD006996.pub2. Cochrane Database Syst Rev. 2009. PMID: 19370666 Free PMC article. Review.

Cited by

• Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes.

  Kobayashi T, Ikeda K, Kumanishi T. Kobayashi T, et al. Br J Pharmacol. 2000 Apr;129(8):1716-22. doi: 10.1038/sj.bjp.0703224. Br J Pharmacol. 2000. PMID: 10780978 Free PMC article.

• [Lengthening of QT interval by antipsychotic drugs].

  Haverkamp W, Deuschle M. Haverkamp W, et al. Nervenarzt. 2006 Mar;77(3):276, 278-80, 282-4 passim. doi: 10.1007/s00115-005-1966-x. Nervenarzt. 2006. PMID: 16052325 Review. German.

• Adverse effects of antipsychotic agents. Do newer agents offer advantages?

  Owens DG. Owens DG. Drugs. 1996 Jun;51(6):895-930. doi: 10.2165/00003495-199651060-00001. Drugs. 1996. PMID: 8736614 Review.

• Antipsychotic-related QTc prolongation, torsade de pointes and sudden death.

  Haddad PM, Anderson IM. Haddad PM, et al. Drugs. 2002;62(11):1649-71. doi: 10.2165/00003495-200262110-00006. Drugs. 2002. PMID: 12109926 Review.

• Variability of heart rate correction methods for the QT interval.

  Desai M, Li L, Desta Z, Malik M, Flockhart D. Desai M, et al. Br J Clin Pharmacol. 2003 Jun;55(6):511-7. doi: 10.1046/j.1365-2125.2003.01791.x. Br J Clin Pharmacol. 2003. PMID: 12814443 Free PMC article. Clinical Trial.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon

• Medical

  • MedlinePlus Health Information